Abstract
This chapter contains sections titled: Introduction Definition Regulatory considerations Biotechnology versus conventional drug products Manufacturing issues Product classes and resultant clinical trial issues Peptides Gene therapy Cell and tissue products General ethical issues Pharmacogenomics as it applies to biotechnology product development Acknowledgments and Further reading
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have